Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.65B |
| Enterprise value | 2.28B |
| Trailing P/E | 26.28 |
| Forward P/E | 21.37 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.53 |
| Price/book (mrq) | 5.98 |
| Enterprise value/revenue | 5.81 |
| Enterprise value/EBITDA | 16.98 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.56 |
| 52-week change 3 | 32.32% |
| S&P500 52-week change 3 | -13.66% |
| 52-week high 3 | 29.93 |
| 52-week low 3 | 15.83 |
| 50-day moving average 3 | 26.82 |
| 200-day moving average 3 | 23.02 |
Share statistics
| Avg vol (3-month) 3 | 616.61k |
| Avg vol (10-day) 3 | 579.83k |
| Shares outstanding 5 | 107.11M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 87.44M |
| % held by insiders 1 | 11.16% |
| % held by institutions 1 | 80.79% |
| Shares short (30 Aug 2022) 4 | 17.35M |
| Short ratio (30 Aug 2022) 4 | 29.25 |
| Short % of float (30 Aug 2022) 4 | 25.02% |
| Short % of shares outstanding (30 Aug 2022) 4 | 16.20% |
| Shares short (prior month 28 July 2022) 4 | 17.93M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 June 2022 |
Profitability
| Profit margin | 28.76% |
| Operating margin (ttm) | 33.44% |
Management effectiveness
| Return on assets (ttm) | 15.39% |
| Return on equity (ttm) | 23.36% |
Income statement
| Revenue (ttm) | 392.03M |
| Revenue per share (ttm) | 3.55 |
| Quarterly revenue growth (yoy) | 12.90% |
| Gross profit (ttm) | 360.7M |
| EBITDA | 132.06M |
| Net income avi to common (ttm) | 112.72M |
| Diluted EPS (ttm) | 0.94 |
| Quarterly earnings growth (yoy) | 3.40% |
Balance sheet
| Total cash (mrq) | 370.09M |
| Total cash per share (mrq) | 3.45 |
| Total debt (mrq) | 2.26M |
| Total debt/equity (mrq) | 0.51 |
| Current ratio (mrq) | 8.54 |
| Book value per share (mrq) | 4.15 |
Cash flow statement
| Operating cash flow (ttm) | 151.42M |
| Levered free cash flow (ttm) | 123.13M |
© 2022 Yahoo. All rights reserved.
